HomeComparePTAIY vs PFE

PTAIY vs PFE: Dividend Comparison 2026

PTAIY yields 6.34% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTAIY wins by $24481.26M in total portfolio value
10 years
PTAIY
PTAIY
● Live price
6.34%
Share price
$7.73
Annual div
$0.49
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24481.31M
Annual income
$23,761,215,165.01
Full PTAIY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — PTAIY vs PFE

📍 PTAIY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTAIYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTAIY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTAIY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTAIY
Annual income on $10K today (after 15% tax)
$538.81/yr
After 10yr DRIP, annual income (after tax)
$20,197,032,890.26/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PTAIY beats the other by $20,197,010,570.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTAIY + PFE for your $10,000?

PTAIY: 50%PFE: 50%
100% PFE50/50100% PTAIY
Portfolio after 10yr
$12240.68M
Annual income
$11,880,620,711.86/yr
Blended yield
97.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PTAIY
No analyst data
Altman Z
2.4
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTAIY buys
0
PFE buys
0
No recent congressional trades found for PTAIY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTAIYPFE
Forward yield6.34%6.13%
Annual dividend / share$0.49$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$24481.31M$49.6K
Annual income after 10y$23,761,215,165.01$26,258.71
Total dividends collected$24431.57M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PTAIY vs PFE ($10,000, DRIP)

YearPTAIY PortfolioPTAIY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,968$1,267.79$9,153$693.39+$2.8KPTAIY
2$15,642$2,836.00$8,593$849.25+$7.0KPTAIY
3$23,665$6,928.17$8,336$1,066.78+$15.3KPTAIY
4$44,913$19,592.26$8,437$1,384.80+$36.5KPTAIY
5$117,561$69,503.61$9,013$1,875.40+$108.5KPTAIY
6$465,839$340,048.41$10,306$2,680.72+$455.5KPTAIY
7$3,017,048$2,518,601.06$12,820$4,101.38+$3.00MPTAIY
8$33,717,888$30,489,646.00$17,673$6,826.70+$33.70MPTAIY
9$672,986,114$636,907,974.20$27,543$12,591.86+$672.96MPTAIY
10$24,481,310,307$23,761,215,165.01$49,560$26,258.71+$24481.26MPTAIY

PTAIY vs PFE: Complete Analysis 2026

PTAIYStock

PT Astra International Tbk, together with its subsidiaries, operates in the automotive, financial services, heavy equipment, mining, construction, energy, agri, infrastructure and logistics, information technology, and property businesses in Indonesia. It offers cars, trucks, and motorcycles of various brands; manufactures and sells automotive components to the original equipment for manufacturers and replacement markets, as well as provides consultation services to its customers; financing for cars, motorcycles, and heavy equipment; life, vehicle, and health insurance, as well as other insurance for commercial business; and various banking products and services. The company also distributes heavy equipment for the mining, plantation, construction, forestry, transportation, and material handling industries; provides coal mining contracting services; operates coal mines; and produces crude palm oil. In addition, it is involved in the operation of toll roads; rental of vehicles; sale of used cars; and provision of logistics and warehousing services, as well as freight forwarding service through ground, sea, and air transportation. Further, the company offers various information technology business solutions based on document, information, and communication technology; and engages in the property development and management activities. Additionally, it is involved in the foundation; formwork and bekisting; pump services; and mechanical, electrical, and plumbing works. The company was incorporated in 1957 and is headquartered in Jakarta, Indonesia. PT Astra International Tbk is a subsidiary of Jardine Cycle & Carriage Limited.

Full PTAIY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PTAIY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTAIY vs SCHDPTAIY vs JEPIPTAIY vs OPTAIY vs KOPTAIY vs MAINPTAIY vs JNJPTAIY vs MRKPTAIY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.